Walder Wyss advised ExcellGene and Magellan Biologics & Consulting Global, on the sale of a majority stake to private equity healthcare specialist Archimed. The deal sets to create a group covering gene transfer, cell line
Walder Wyss advised ExcellGene and Magellan Biologics & Consulting Global, on the sale of a majority stake to private equity healthcare specialist Archimed. The deal sets to create a group covering gene transfer, cell line